Cargando…

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

Detalles Bibliográficos
Autores principales:	Lim, Sean H, Campbell, Nicola, Johnson, Marina, Joseph-Pietras, Debora, Collins, Graham P, O'Callaghan, Ann, Fox, Christopher P, Ahearne, Matthew, Johnson, Peter W M, Goldblatt, David, Davies, Andrew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253538/ https://www.ncbi.nlm.nih.gov/pubmed/34224667 http://dx.doi.org/10.1016/S2352-3026(21)00199-X

Ejemplares similares

Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study
por: Lim, Sean H., et al.
Publicado: (2022)

SARS-CoV-2: from herd immunity to hybrid immunity
por: Goldblatt, David
Publicado: (2022)

Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507)
por: Tempo, Jake, et al.
Publicado: (2023)

Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma
por: Hasserjian, Robert P., et al.
Publicado: (2009)

Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas
por: Balague Ponz, Olga, et al.
Publicado: (2009)

Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
por: Ott, German, et al.
Publicado: (2009)

WHO international standard for SARS-CoV-2 antibodies to determine markers of protection
por: Zhu, Feng, et al.
Publicado: (2022)

Antibodies, epicenter of SARS-CoV-2 immunology
por: Pecetta, Simone, et al.
Publicado: (2021)

IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Dissecting antibody-mediated protection against SARS-CoV-2
por: Zohar, Tomer, et al.
Publicado: (2020)

SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA
por: Flower, Barnaby, et al.
Publicado: (2020)

Systemic lupus erythematosus does not prevent antibody responses to SARS-CoV-2
por: Aringer, Martin
Publicado: (2021)

SARS-CoV-2 vaccine-induced antibody levels: what lies beneath
por: Lassaunière, Ria, et al.
Publicado: (2022)

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
por: Bachmann, Martin F., et al.
Publicado: (2021)

B cells: more than just for antibodies in SARS-CoV-2 vaccine responses
por: Paley, Michael A, et al.
Publicado: (2021)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
por: Ju, Yi, et al.
Publicado: (2022)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2
por: Strugnell, Richard, et al.
Publicado: (2021)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
por: Raiden, Silvina, et al.
Publicado: (2021)

COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria
por: Pike, Alexandra, et al.
Publicado: (2022)

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
por: Goulenok, Tiphaine, et al.
Publicado: (2022)

Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
por: Wallwork, Rachel, et al.
Publicado: (2022)

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK
por: Nadesalingam, Angalee, et al.
Publicado: (2021)

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis
por: Shao, Yacong, et al.
Publicado: (2022)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
por: Frey, Sarah, et al.
Publicado: (2022)

Managing fragility fractures during the COVID-19 pandemic
por: Napoli, Nicola, et al.
Publicado: (2020)

Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
por: Aurer, Igor, et al.
Publicado: (2020)

Spreading of SARS-CoV-2 from hamsters to humans
por: Haagmans, Bart L, et al.
Publicado: (2022)

Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Comment on Hogas et al. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175
por: Campbell, Norm R. C., et al.
Publicado: (2022)

SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission
por: Fearon, Elizabeth, et al.
Publicado: (2021)

Open questions on the photophysics of ultrafast singlet fission
por: Johnson, Justin C.
Publicado: (2021)

Bringing orthogeriatric care for elderly patients with hip fractures to Asia
por: Ho, Sean Wei Loong, et al.
Publicado: (2022)

SARS-CoV-2 severity in African Americans – a role for Duffy null?
por: Hebbel, Robert P., et al.
Publicado: (2020)

Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
por: Li, Pengfei, et al.
Publicado: (2022)

Passive antibody therapy in COVID-19
por: Abraham, Jonathan
Publicado: (2020)

Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems
por: Moore, Luke S P
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ada2b9dl7ria6iacmbgmqt6dhe